ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma.

Motonobu Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.